Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Convenient Manassas location at 8551 Rixlew Lane Suite 140A Experienced medical staff specializing in weight management Personalized treatment plans Ongoing support for long-term success How to Get Started
Novo Nordisk Press Release: Zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes presented at ADA 2026
doi: 10.1007/s00125-022-05787-2
PlexusDx partners exclusively with licensed 503A compounding pharmacies that perform stability testing on each batch
At 48 weeks, preliminary results of the high dose bimagrumab-semaglutide combination resulted in 20.2% mean weight change with lean muscle mass largely preserved (2.6% decrease in lean mass versus 7.9% with high dose semaglutide and 0.5% with placebo, measured by DXA)
Immune support + pain/nausea relief
US$ 25.35
US$ 23.14
US$ 21.01
US$ 22.39
US$ 29.10
US$ 28.93
US$ 25.40
